These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 23095244)

  • 1. Subacute effects of ecstasy on mood: an exploration of associated risk factors.
    Scott RM; Hides L; Allen JS; Lubman DI
    J Psychopharmacol; 2013 Jan; 27(1):53-61. PubMed ID: 23095244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coping style and ecstasy use motives as predictors of current mood symptoms in ecstasy users.
    Scott RM; Hides L; Allen JS; Lubman DI
    Addict Behav; 2013 Oct; 38(10):2465-72. PubMed ID: 23770644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of comorbid cannabis and methamphetamine use on mental health among regular ecstasy users.
    Scott LA; Roxburgh A; Bruno R; Matthews A; Burns L
    Addict Behav; 2012 Sep; 37(9):1058-62. PubMed ID: 22607716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An investigation of the subacute effects of ecstasy on neuropsychological performance, sleep and mood in regular ecstasy users.
    Pirona A; Morgan MJ
    J Psychopharmacol; 2010 Feb; 24(2):175-85. PubMed ID: 19351799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An investigation into the sub-acute effects of ecstasy on aggressive interpretative bias and aggressive mood - are there gender differences?
    Hoshi R; Pratt H; Mehta S; Bond AJ; Curran HV
    J Psychopharmacol; 2006 Mar; 20(2):291-301. PubMed ID: 16510487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An investigation of factors associated with depressive symptoms among a sample of regular ecstasy consumers.
    Matthews AJ; Bruno R
    Neuropsychobiology; 2010; 61(4):215-22. PubMed ID: 20389132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Male and female ecstasy users: differences in patterns of use, sleep quality and mental health outcomes.
    Ogeil RP; Rajaratnam SM; Broadbear JH
    Drug Alcohol Depend; 2013 Sep; 132(1-2):223-30. PubMed ID: 23453259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between the negative effects attributed to ecstasy use and measures of cognition and mood among users.
    Fisk JE; Montgomery C; Murphy PN
    Exp Clin Psychopharmacol; 2009 Oct; 17(5):326-36. PubMed ID: 19803632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antidepressant-like effects of ecstasy in subjects with a predisposition to depression.
    Majumder I; White JM; Irvine RJ
    Addict Behav; 2012 Oct; 37(10):1189-92. PubMed ID: 22704044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sub-acute effects of MDMA (+/-3,4-methylenedioxymethamphetamine, "ecstasy") on mood: evidence of gender differences.
    Verheyden SL; Hadfield J; Calin T; Curran HV
    Psychopharmacology (Berl); 2002 Apr; 161(1):23-31. PubMed ID: 11967627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ecstasy (MDMA) and high prevalence psychiatric symptomatology: somatic anxiety symptoms are associated with polydrug, not ecstasy, use.
    Bedi G; Van Dam NT; Redman J
    J Psychopharmacol; 2010 Feb; 24(2):233-40. PubMed ID: 18832429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The sub-acute effects of recreational ecstasy (MDMA) use: a controlled study in humans.
    Huxster JK; Pirona A; Morgan MJ
    J Psychopharmacol; 2006 Mar; 20(2):281-90. PubMed ID: 16510486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Problematic versus non-problematic ecstasy/MDMA use: the influence of drug usage patterns and pre-existing psychiatric factors.
    Soar K; Turner JJ; Parrott AC
    J Psychopharmacol; 2006 May; 20(3):417-24. PubMed ID: 16574716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contextualising psychological distress among regular ecstasy users: the importance of sociodemographic factors and patterns of drug use.
    George J; Kinner SA; Bruno R; Degenhardt L; Dunn M
    Drug Alcohol Rev; 2010 May; 29(3):243-9. PubMed ID: 20565515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pattern of cannabis use in ecstasy polydrug users: moderate cannabis use may compensate for self-rated aggression and somatic symptoms.
    Milani RM; Parrott AC; Schifano F; Turner JJ
    Hum Psychopharmacol; 2005 Jun; 20(4):249-61. PubMed ID: 15816011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depressive and anxiety symptomatology in ecstasy users: the relative contribution of genes, trauma, life stress and drug use.
    Scott RM; Hides L; Allen JS; Burke R; Lubman DI
    Psychopharmacology (Berl); 2010 Mar; 209(1):25-36. PubMed ID: 20101393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ecstasy use and self-reported disturbances in sleep.
    Ogeil RP; Rajaratnam SM; Phillips JG; Redman JR; Broadbear JH
    Hum Psychopharmacol; 2011 Oct; 26(7):508-16. PubMed ID: 21953704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mood and cognitive effects of +/-3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy'): week-end 'high' followed by mid-week low.
    Curran HV; Travill RA
    Addiction; 1997 Jul; 92(7):821-31. PubMed ID: 9293041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of acute psychotic episode after a single dose of ecstasy].
    Vaiva G; Bailly D; Boss V; Thomas P; Lestavel P; Goudemand M
    Encephale; 2001; 27(2):198-202. PubMed ID: 11407274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathways to ecstasy use in young adults: anxiety, depression or behavioural deviance?
    Alati R; Kinner SA; Hayatbakhsh MR; Mamun AA; Najman JM; Williams GM
    Drug Alcohol Depend; 2008 Jan; 92(1-3):108-15. PubMed ID: 17850992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.